FEV1 Improvements with Tiotropium & Long-Acting Beta2-Agonists Added to Inhaled Corticosteroid Therapy Are Similar in Pediatric Patients with Asthma.

被引：0

作者：

Vogelberg, C. ^{[1
]}

Goldstein, S. ^{[2
]}

Graham, L. ^{[3
]}

Szefler, S. ^{[4
,5
]}

El Azzi, G. ^{[6
]}

Kallsen, K. ^{[6
]}

Hamelmann, E. ^{[7
,8
]}

机构：

[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Pediat Pulmonol & Allergy, Dresden, Germany

[2] Allergy & Asthma Care Long Isl, Rockville Ctr, NY USA

[3] Childrens Healthcare Atlanta, Pediat Pulmonol, Atlanta, GA USA

[4] Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA

[5] Univ Colorado, Sch Med, Breathing Inst, Aurora, CO USA

[6] Boehringer Ingelheim Pharma GmbH & Co KG, TA Resp Dis, Ingelheim, Germany

[7] Evangel Klinikum Bethel, Klin Kinder & Jugendmed, Bielefeld, Germany

[8] Ruhr Univ, Allergy Ctr, Bochum, Germany

来源：

PEDIATRIC PULMONOLOGY | 2018年 / 53卷

关键词：

D O I：

暂无

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

A67

引用

页码：S97 / S100

页数：4

共 50 条

[41] Combined corticosteroid and long-acting beta2-agonist in one inhaler versus long-acting beta2-agonists for chronic obstructive pulmonary disease
Javier Nannini, Luis
Lasserson, Toby J.
Poole, Phillippa
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (09):
[42] The safety of regular long-acting beta2-agonists in children with asthma: an overview of Cochrane reviews
Cates, Chris
PAEDIATRIC RESPIRATORY REVIEWS, 2013, 14 (01) : 25 - 26
[43] EFFICACY OF INHALED TIOTROPIUM FOR ASTHMATICS UNCONTROLLED USING INHALED CORTICOSTEROID PLUS A LONG-ACTING BETA2-AGONIST
Nsouli, S.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S53 - S53
[44] Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2 - agonists (LABA) for adults with asthma
Kew, Kayleigh M.
Evans, David J. W.
Allison, Debbie E.
Boyter, Anne C.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (06):
[45] WASTEFUL HEALTHCARE SPENDING ON MEDICATION OVERSUPPLY IN ROUTINE USES OF COMBINED INHALED CORTICOSTEROID AND LONG-ACTING BETA2-AGONISTS (ICS/LABA) INHALERS
Tanvejsilp, P.
Nilmoje, C.
Sukhsawat, K.
VALUE IN HEALTH, 2018, 21 : S416 - S416
[46] Tiotropium added to inhaled corticosteroids and long-acting β2-agonists reduces episodes of asthma worsening, irrespective of selected patient baseline characteristics
Kerstjens, H. A. M.
Engel, M.
Moroni-Zentgraf, P.
Schmidt, H.
Bateman, E.
ALLERGY, 2013, 68 : 41 - 41
[47] A Safety Review of Long-Acting beta(2)-Agonists in Patients With Asthma
Rider, Nicholas L.
Craig, Timothy J.
JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2006, 106 (09): : 562 - 567
[48] Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β2-agonists for adults with asthma
Buhl, Roland
FitzGerald, J. Mark
Busse, William W.
RESPIRATORY MEDICINE, 2018, 143 : 82 - 90
[49] Inhaled corticosteroids plus long-acting β2-agonists as a combined therapy in asthma
García-Marcos, L
Schuster, A
Barroso, NC
EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (01) : 23 - 39
[50] Impact of Omalizumab Initiation on Emergency-Department Visits, Hospitalizations and Corticosteroid Use in Patients with Uncontrolled Asthma Using High-Dose Inhaled Corticosteroids and Long-Acting Beta2-Agonists
Lafeuille, Marie-Helene
Dean, Jason
Zhang, Jie
Duh, Mei Sheng
Gorsh, Boris
Lefebvre, Patrick
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 21 - 21

← 1 2 3 4 5 →